ConductScience.org, home

Paper14660

Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.

Marlin GE and 2 others. Br J Clin Pharmacol, 1977. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols. Papers, record 14660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14660

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marlin GEG E
2Hartnett BJB J
3Berend NN

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlbuterolMajor topic
CatecholsMajor topic
PiperidinesMajor topic
Receptors, AdrenergicMajor topic
Receptors, Adrenergic, betaMajor topic
Adult
Aerosols
Aged
Airway Obstruction
Bronchodilator Agents
Forced Expiratory Volume
Heart Rate
Humans
Middle Aged
Placebos

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,940Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.Br J Clin Pharmacol1975https://conductscience.org/library/papers/10940PubMed
21,116,382Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.Curr Med Res Opin1975https://conductscience.org/library/papers/1116382PubMed
31,139,193Intravenous treatment with rimiterol and salbutamol in asthma.Br Med J1975https://conductscience.org/library/papers/1139193PubMed
4240,780The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.Int J Clin Pharmacol Biopharm1975https://conductscience.org/library/papers/240780PubMed
54,147,213Clinical assessment of bronchodilator drugs delivered by aerosol.Thorax1973https://conductscience.org/library/papers/4147213PubMed
64,401,704A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man.J Clin Pharmacol New Drugs1972https://conductscience.org/library/papers/4401704PubMed
74,402,115Comparison of the bronchodilatory action of two drugs.Int Z Klin Pharmakol Ther Toxikol1971https://conductscience.org/library/papers/4402115PubMed
84,404,808The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.Scand J Respir Dis1972https://conductscience.org/library/papers/4404808PubMed
94,932,744Preliminary studies of a new bronchodilator (WG 253) in man.J Clin Pharmacol New Drugs1971https://conductscience.org/library/papers/4932744PubMed
105,411,446Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.Br Med J1970https://conductscience.org/library/papers/5411446PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
6,117,302Effect of intravenous injection of rimiterol in asthma.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6117302PubMed
533,582Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.Br J Clin Pharmacol1979https://conductscience.org/library/papers/533582PubMed
19,226Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.Drugs1977https://conductscience.org/library/papers/19226PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ADRB2154PubTator's text mininghttps://conductscience.org/library/genes/154

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14660

GET https://conductscience.org/api/papers/v1/14660/authors